Efficacy and Tolerability of Aripiprazole in a Nigerian Cohort with First-episode Psychosis: A Post-marketing Survey

Journal Title: International Neuropsychiatric Disease Journal - Year 2017, Vol 10, Issue 1

Abstract

Background: Individuals with first episode psychoses often discontinue pharmacotherapy due to poor symptom remission and/or intolerable side effects. Aripiprazole has been reported to show good efficacy with low side effect profiles in Caucasians. No studies have been conducted to assess its effectiveness and tolerability in a Nigerian population hence the need for this study. Methods: A post marketing surveillance was conducted involving patients with first episode psychosis presenting to a regional tertiary psychiatric facility in Nigeria. Participants were titrated through a dose range of 10-30 mg of aripiprazole depending on response or tolerability and followed up over a 12 week period. Assessments at baseline, at 2, 6, and 12-weeks post recruitment were done to rate severity of psychopathology (CGI, PANSS), side effects (MSAS), functioning (GAF), and medication adherence (MARS). Results: Of fifty patients completing the study (49.5% drop-out rate), we observed significant improvements at 12 weeks compared to baseline in symptom remission (p<0.001), clinician rating of improvement (p<0.01), and psychosocial functioning (p<0.001). There were no significant changes compared to baseline as regards medication adherence, extra pyramidal side effects (p=0.23), fasting blood sugar (p=0.67) and fasting cholesterol (p=0.57) Conclusion: Aripiprazole may be effective and tolerable among individuals with first episode non-affective psychoses presenting at a tertiary psychiatric facility in Nigeria.

Authors and Affiliations

S. O. Olotu, I. O. Agbonile, J. O. Omoaregba, B. O. James

Keywords

Related Articles

Subjective Experiences of Antipsychotic Treatment: A Comparison of First- and Second-generation Medications among Patients with Schizophrenia

Aims: The patient’s perspective of antipsychotic treatment has been a relatively neglected area of research. Whether subjective experiences of antipsychotic treatment are better among patients on second-generation antips...

Nasal Septum Deviation is Not a Cause of Migraine or Tension Headache

Objective and Aim: Nasal septum deviation (NSD) is an important otorhinolaryngologic cause of headache. We evaluated the frequency of common forms of headache in subjects with NSD. Methods: All participants underwent exa...

Psychological Predictors of Premenstrual Syndrome

Background: Premenstrual syndrome (PMS) is one the most common gynecological conditions that can impact an individual’s interpersonal relationships, social interactions, academic performance, and emotional well-being. O...

Verbal Fluency is Related to Theory of Mind: Comparison in Control Children and with Autism Spectrum Disorder

Autism is a pervasive neurodevelopment disorder, primarily encompassing difficulties in the social, language, and communicative domains. Although neurocognitive impairments in theory of mind (ToM) and in executive functi...

A Case of Polydipsia in a Psychiatric Patient

A 28 year old male student, with a long standing history of psychotic disorder, presented with excessive water intake and symptom exacerbation with associated confusion, vomiting and irrational talk, that has started a w...

Download PDF file
  • EP ID EP308482
  • DOI 10.9734/INDJ/2017/34977
  • Views 120
  • Downloads 0

How To Cite

S. O. Olotu, I. O. Agbonile, J. O. Omoaregba, B. O. James (2017). Efficacy and Tolerability of Aripiprazole in a Nigerian Cohort with First-episode Psychosis: A Post-marketing Survey. International Neuropsychiatric Disease Journal, 10(1), 1-10. https://europub.co.uk./articles/-A-308482